Primary Gonarthrosis Clinical Trial
Official title:
Department of Orthopaedics Faculty of Medicine Thammasat University Thailand
The purpose of this study is to explore the effects of the Oxford unicompartmental knee
arthroplasty on two groups of patients, namely one with genu recurvatum before the procedure
and one without. Specifically, this study compare the number of occurrences of postoperative
genu recurvatum and the postoperative hyperextension angles among the patients. Additionally,
the knee scores, the pain scores, and the functional scores for the two groups of patients
are compared.
Materials and methods: This study prospectively followed 104 patients (114 knees) who had
been treated with cemented minimally invasive surgery unicompartmental knee arthroplasty and
had had a minimum of 24 months of follow-up. The patients were divided into two groups: those
without preoperative genu recurvatum (85 patients; 94 knees) and those with preoperative genu
recurvatum (19 patients; 20 knees). The incidence of the postoperative genu recurvatum, the
postoperative hyperextension angles, the knee scores, the pain scores, and the functional
scores were recorded and compared between two groups..
The patients in both groups were applied with cemented Oxford unicompartmental knee arthroplasty with the same surgeon. The all patients were performed surgery with minimally invasive surgery technique. The gender, site, range of motion, alignment of prosthesis, operative time, blood loss, and posterior slope of tibial component also were recorded and compared between two groups. The incidence of postoperative genu recurvatum, gender, and site were computed using Fisher's exact test. The hyperextension angle, knee score, pain score, functional score,range of motion, alignment of prosthesis, posterior slope of tibial component, operative time, and blood loss were compared with student t-test. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05806021 -
The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis
|
Phase 4 |